The neighboring DARPP-32 gene codes for a Dopamine and cAMP-regulated phosphoprotein, and its over-expression has been implicated in resistance to tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor targeted therapy in cancer [34]. This evidence concerns the gene PPP1R1B and cancer.